195 filings
Page 5 of 10
8-K
v5oddfy5n7pvp78g
2 Dec 20
Entry into a Material Definitive Agreement
5:08pm
424B5
0n69j5lj5 lbx5ysictv
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B3
2s5as3gkv1 bas
2 Dec 20
Prospectus supplement
12:00am
424B5
0si dfxcrijs3
30 Nov 20
Prospectus supplement for primary offering
5:28pm
8-K
8zrzcttcaa9545
30 Nov 20
Other Events
5:06pm
8-K
gdz0d
9 Nov 20
Cogent Biosciences Reports Third Quarter 2020
7:33am
S-8
a92jxce5sjo06pe5v0p
5 Nov 20
Registration of securities for employees
5:02pm
8-K
gy0u pns4
26 Oct 20
Cogent Biosciences Appoints
7:13am
8-K
o3zq86cxappb2p97at
23 Oct 20
Departure of Directors or Certain Officers
4:11pm
EFFECT
tmgssjv4vb
16 Oct 20
Notice of effectiveness
12:15am
UPLOAD
9lgi iok8k75
13 Oct 20
Letter from SEC
12:00am
CORRESP
k5zs wmbtrfy5ui
13 Oct 20
Correspondence with SEC
12:00am
DEFM14A
89w0s
9 Oct 20
Proxy related to merger
4:44pm
UPLOAD
l18jxyunrzwu28gyih7x
6 Oct 20
Letter from SEC
12:00am
CORRESP
rje8 abe4fyc24z
6 Oct 20
Correspondence with SEC
12:00am
8-K
o1y19 ln6770
5 Oct 20
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress
9:08am